Skip to main content
Premium Trial:

Request an Annual Quote

GenTel Obtains Rights From Van Andel Research Institute to Sell Protein Array Tool

NEW YORK (GenomeWeb News) – The Van Andel Research Institute granted GenTel Biosciences exclusive rights to use its technology to commercialize a microarray platform that measures variations in protein glycosylation.
 
GenTel plans to use the technology with its PANDEIAT system to label serum proteins and probe cancer biomarker-specific antibody arrays to measure both the protein abundance and the degree of protein glycosylation, the company said.
 
Financial details were not disclosed.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.